Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care

Ali E Denktas1, H Vernon Anderson, James McCarthy

  • 1University of Texas, Health Science Center at Houston and Memorial Hermann Heart and Vascular Institute, Houston, Texas, USA.

Insights

Focusing solely on hospital treatment times for ST-segment elevation myocardial infarction (STEMI) overlooks critical pre-hospital ischemia. Total ischemic time, from symptom onset to reperfusion, strongly correlates with infarct size and mortality.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Quality Improvement

Background:

  • Current ST-segment elevation myocardial infarction (STEMI) quality metrics primarily assess in-hospital processes, such as door-to-balloon time.
  • These metrics neglect the significant duration of myocardial ischemia occurring before hospital admission.
  • A substantial proportion of STEMI-related mortality happens during the pre-hospital phase.

Purpose of the Study:

  • To review the critical importance of total ischemic time in STEMI management.
  • To highlight the limitations of focusing solely on in-hospital metrics.
  • To advocate for a broader perspective on STEMI care quality.

Main Methods:

  • Literature review of experimental and human clinical studies.
  • Analysis of the correlation between ischemic time intervals and patient outcomes.
  • Discussion of the impact of pre-hospital ischemia on STEMI.

Main Results:

  • Total ischemic time, encompassing pre-hospital duration, is a stronger predictor of infarct size and mortality than door-to-balloon time.
  • Infarct size and mortality show a significant correlation with the total duration of ischemia from symptom onset to reperfusion.
  • Sub-intervals of care, like door-to-balloon time, have a comparatively weaker association with outcomes.

Conclusions:

  • Quality of care standards for STEMI should incorporate total ischemic time, not just in-hospital metrics.
  • Addressing pre-hospital ischemia is crucial for reducing STEMI-related mortality and improving patient outcomes.
  • A comprehensive approach to STEMI care requires evaluating the entire patient journey from symptom onset to definitive treatment.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...